Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Impact of Pharmacologic Inhibition of Tooth Movement on Periodontal and Tooth Root Tissues During Orthodontic Force Application.

Baxter SJ, Sydorak I, Ma PX, Hatch NE.

Orthod Craniofac Res. 2019 Oct 8. doi: 10.1111/ocr.12350. [Epub ahead of print]

PMID:
31593373
2.

A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib.

Chaturvedi NK, Hatch ND, Sutton GL, Kling M, Vose JM, Joshi SS.

Leuk Lymphoma. 2019 May;60(5):1214-1223. doi: 10.1080/10428194.2018.1520986. Epub 2018 Nov 14.

PMID:
30424705
3.

Tissue nonspecific alkaline phosphatase promotes calvarial progenitor cell cycle progression and cytokinesis via Erk1,2.

Nam HK, Vesela I, Siismets E, Hatch NE.

Bone. 2019 Mar;120:125-136. doi: 10.1016/j.bone.2018.10.013. Epub 2018 Oct 17.

PMID:
30342227
4.

Pore size directs bone marrow stromal cell fate and tissue regeneration in nanofibrous macroporous scaffolds by mediating vascularization.

Gupte MJ, Swanson WB, Hu J, Jin X, Ma H, Zhang Z, Liu Z, Feng K, Feng G, Xiao G, Hatch N, Mishina Y, Ma PX.

Acta Biomater. 2018 Dec;82:1-11. doi: 10.1016/j.actbio.2018.10.016. Epub 2018 Oct 13.

PMID:
30321630
5.

Microsphere controlled drug delivery for local control of tooth movement.

Sydorak I, Dang M, Baxter SJ, Halcomb M, Ma P, Kapila S, Hatch N.

Eur J Orthod. 2019 Jan 23;41(1):1-8. doi: 10.1093/ejo/cjy017.

6.

Postnatal Craniofacial Skeletal Development of Female C57BL/6NCrl Mice.

Wei X, Thomas N, Hatch NE, Hu M, Liu F.

Front Physiol. 2017 Sep 14;8:697. doi: 10.3389/fphys.2017.00697. eCollection 2017.

7.

ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.

Balek L, Gudernova I, Vesela I, Hampl M, Oralova V, Kunova Bosakova M, Varecha M, Nemec P, Hall T, Abbadessa G, Hatch N, Buchtova M, Krejci P.

Bone. 2017 Dec;105:57-66. doi: 10.1016/j.bone.2017.08.016. Epub 2017 Aug 18.

PMID:
28826843
8.

Analysis of polycaprolactone scaffolds fabricated via precision extrusion deposition for control of craniofacial tissue mineralization.

Fedore CW, Tse LYL, Nam HK, Barton KL, Hatch NE.

Orthod Craniofac Res. 2017 Jun;20 Suppl 1:12-17. doi: 10.1111/ocr.12159.

PMID:
28643920
9.

Diffusional Kurtosis Imaging of the Corticospinal Tract in Multiple Sclerosis: Association with Neurologic Disability.

Spampinato MV, Kocher MR, Jensen JH, Helpern JA, Collins HR, Hatch NU.

AJNR Am J Neuroradiol. 2017 Aug;38(8):1494-1500. doi: 10.3174/ajnr.A5225. Epub 2017 Jun 1.

10.

Tissue Nonspecific Alkaline Phosphatase (TNAP) Regulates Cranial Base Growth and Synchondrosis Maturation.

Nam HK, Sharma M, Liu J, Hatch NE.

Front Physiol. 2017 Mar 21;8:161. doi: 10.3389/fphys.2017.00161. eCollection 2017.

11.

Galaxy formation through cosmic recycling.

Hatch N.

Science. 2016 Dec 2;354(6316):1102-1103. No abstract available.

PMID:
27934721
12.

Bone mineralization-dependent craniosynostosis and craniofacial shape abnormalities in the mouse model of infantile hypophosphatasia.

Durussel J, Liu J, Campbell C, Nam HK, Hatch NE.

Dev Dyn. 2016 Feb;245(2):175-82. doi: 10.1002/dvdy.24370. Epub 2015 Dec 28.

13.

Inhibition of osteoblast mineralization by phosphorylated phage-derived apatite-specific peptide.

Ramaswamy J, Nam HK, Ramaraju H, Hatch NE, Kohn DH.

Biomaterials. 2015 Dec;73:120-30. doi: 10.1016/j.biomaterials.2015.09.021. Epub 2015 Sep 15.

14.

Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.

Liu J, Campbell C, Nam HK, Caron A, Yadav MC, Millán JL, Hatch NE.

Bone. 2015 Sep;78:203-11. doi: 10.1016/j.bone.2015.05.005. Epub 2015 May 8.

15.
16.

Locally limited inhibition of bone resorption and orthodontic relapse by recombinant osteoprotegerin protein.

Schneider DA, Smith SM, Campbell C, Hayami T, Kapila S, Hatch NE.

Orthod Craniofac Res. 2015 Apr;18 Suppl 1:187-95. doi: 10.1111/ocr.12086.

PMID:
25865548
17.

Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia.

Foster BL, Sheen CR, Hatch NE, Liu J, Cory E, Narisawa S, Kiffer-Moreira T, Sah RL, Whyte MP, Somerman MJ, Millán JL.

J Dent Res. 2015 May;94(5):706-14. doi: 10.1177/0022034515573273. Epub 2015 Feb 25.

18.

Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.

Gasque KC, Foster BL, Kuss P, Yadav MC, Liu J, Kiffer-Moreira T, van Elsas A, Hatch N, Somerman MJ, Millán JL.

Bone. 2015 Mar;72:137-47. doi: 10.1016/j.bone.2014.11.017. Epub 2014 Nov 26.

19.

Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.

Liu J, Nam HK, Campbell C, Gasque KC, Millán JL, Hatch NE.

Bone. 2014 Oct;67:81-94. doi: 10.1016/j.bone.2014.06.040. Epub 2014 Jul 9.

20.

Advanced ultrasound procedures.

Hatch N, Wu TS, Barr L, Roque PJ.

Crit Care Clin. 2014 Apr;30(2):305-29, vi. doi: 10.1016/j.ccc.2013.10.005. Epub 2013 Dec 4. Review. Erratum in: Crit Care Clin. 2014 Oct;30(4):xi. Barr, Laurel [added]; Roque, Pedro J [added].

PMID:
24606778
21.

Basic ultrasound-guided procedures.

Barr L, Hatch N, Roque PJ, Wu TS.

Crit Care Clin. 2014 Apr;30(2):275-304, vi. doi: 10.1016/j.ccc.2013.10.004. Epub 2014 Jan 21. Review.

PMID:
24606777
22.

Bedside ocular ultrasound.

Roque PJ, Hatch N, Barr L, Wu TS.

Crit Care Clin. 2014 Apr;30(2):227-41, v. doi: 10.1016/j.ccc.2013.10.007. Epub 2013 Dec 12.

PMID:
24606775
23.
24.

Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.

Liu J, Nam HK, Wang E, Hatch NE.

Calcif Tissue Int. 2013 May;92(5):451-66. doi: 10.1007/s00223-013-9701-2. Epub 2013 Jan 29.

25.

Quantification of external root resorption by low- vs high-resolution cone-beam computed tomography and periapical radiography: A volumetric and linear analysis.

Ponder SN, Benavides E, Kapila S, Hatch NE.

Am J Orthod Dentofacial Orthop. 2013 Jan;143(1):77-91. doi: 10.1016/j.ajodo.2012.08.023.

PMID:
23273363
26.

Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice.

Hatch NW, Srodulski SJ, Chan HW, Zhang X, Tannock LR, King VL.

Gend Med. 2012 Oct;9(5):319-28. doi: 10.1016/j.genm.2012.08.003. Epub 2012 Sep 13.

27.

Deficiency of ACE2 in Bone-Marrow-Derived Cells Increases Expression of TNF-α in Adipose Stromal Cells and Augments Glucose Intolerance in Obese C57BL/6 Mice.

Thatcher SE, Gupte M, Hatch N, Cassis LA.

Int J Hypertens. 2012;2012:762094. doi: 10.1155/2012/762094. Epub 2012 Feb 6.

28.

Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability.

Hudson JB, Hatch N, Hayami T, Shin JM, Stolina M, Kostenuik PJ, Kapila S.

Calcif Tissue Int. 2012 Apr;90(4):330-42. doi: 10.1007/s00223-012-9579-4. Epub 2012 Mar 1.

PMID:
22382900
29.

Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.

Nam HK, Liu J, Li Y, Kragor A, Hatch NE.

J Biol Chem. 2011 Nov 11;286(45):39059-71. doi: 10.1074/jbc.M111.221689. Epub 2011 Sep 19.

30.

Endoscopic removal of a bullet penetrating the middle cranial fossa.

Hatch NU, Riley KO, Woodworth BA.

Skull Base Rep. 2011 May;1(1):47-50. doi: 10.1055/s-0031-1275633. Epub 2011 Mar 30.

31.

Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium.

Alexander NS, Hatch N, Zhang S, Skinner D, Fortenberry J, Sorscher EJ, Woodworth BA.

Laryngoscope. 2011 Jun;121(6):1313-9. doi: 10.1002/lary.21798. Epub 2011 Apr 7.

32.

FGF2 promotes Msx2 stimulated PC-1 expression via Frs2/MAPK signaling.

Li Y, Liu J, Hudson M, Kim S, Hatch NE.

J Cell Biochem. 2010 Dec 1;111(5):1346-58. doi: 10.1002/jcb.22861.

33.

Ask us. Self-ligating bracket claims.

Marshall SD, Currier GF, Hatch NE, Huang GJ, Nah HD, Owens SE, Shroff B, Southard TE, Suri L, Turpin DL.

Am J Orthod Dentofacial Orthop. 2010 Aug;138(2):128-31. No abstract available.

PMID:
20715337
34.

FGF signaling in craniofacial biological control and pathological craniofacial development.

Hatch NE.

Crit Rev Eukaryot Gene Expr. 2010;20(4):295-311. Review.

PMID:
21395503
35.

Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor.

Ge C, Xiao G, Jiang D, Yang Q, Hatch NE, Roca H, Franceschi RT.

J Biol Chem. 2009 Nov 20;284(47):32533-43. doi: 10.1074/jbc.M109.040980. Epub 2009 Sep 30.

36.

A murine model of obesity with accelerated atherosclerosis.

King VL, Hatch NW, Chan HW, de Beer MC, de Beer FC, Tannock LR.

Obesity (Silver Spring). 2010 Jan;18(1):35-41. doi: 10.1038/oby.2009.176. Epub 2009 Jun 4.

37.

FGF2 induced expression of the pyrophosphate generating enzyme, PC-1, is mediated by Runx2 and Msx2.

Hatch NE, Franceschi RT.

J Musculoskelet Neuronal Interact. 2008 Oct-Dec;8(4):318-20. Review. No abstract available.

38.

FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2.

Hatch NE, Li Y, Franceschi RT.

J Bone Miner Res. 2009 Apr;24(4):652-62. doi: 10.1359/jbmr.081213.

39.

Osteoblast differentiation stage-specific expression of the pyrophosphate-generating enzyme PC-1.

Hatch NE, Franceschi RT.

Cells Tissues Organs. 2009;189(1-4):65-9. doi: 10.1159/000151375. Epub 2008 Aug 13.

41.

Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F.

Hatch NE, Hudson M, Seto ML, Cunningham ML, Bothwell M.

J Biol Chem. 2006 Sep 15;281(37):27292-305. Epub 2006 Jul 14.

42.

FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4).

Hatch NE, Nociti F, Swanson E, Bothwell M, Somerman M.

Connect Tissue Res. 2005;46(4-5):184-92.

PMID:
16546821
43.

Clonal expansion of adult rat hepatic stem cell lines by suppression of asymmetric cell kinetics (SACK).

Lee HS, Crane GG, Merok JR, Tunstead JR, Hatch NL, Panchalingam K, Powers MJ, Griffith LG, Sherley JL.

Biotechnol Bioeng. 2003 Sep 30;83(7):760-71.

PMID:
12889016
44.

The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin.

Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV, Sheppard D, Pytela R.

J Biol Chem. 1995 Sep 29;270(39):23196-202.

Supplemental Content

Support Center